Ehret, G. et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature advance online publication, doi: 10.1038/nature10405 (11 September 2011).
Levy, D. et al. Genome-wide association study of blood pressure and hypertension. Nat. Genet. 41, 677–687 (2009).
Newton-Cheh, C. et al. Genome-wide association study identifies eight loci associated with blood pressure. Nat. Genet. 41, 666–676 (2009).
Lawes, C.M. et al. Blood pressure and the global burden of disease 2000. Part II: estimates of attributable burden. J. Hypertens. 24, 423–430 (2006).
Rose, G. Strategies of prevention: the individual and the population. in Coronary Heart Disease Epidemiology: from Aetiology to Public Health (ed. Marmot M, E.P.) 631–41 (Oxford University Press, Oxford, UK, 2005).
Domanski, M.J. et al. Independent prognostic information provided by sphygmomanometrically determined pulse pressure and mean arterial pressure in patients with left ventricular dysfunction. J. Am. Coll. Cardiol. 33, 951–958 (1999).
Domanski, M. et al. Pulse pressure and cardiovascular disease-related mortality: follow-up study of the Multiple Risk Factor Intervention Trial (MRFIT). J. Am. Med. Assoc. 287, 2677–2683 (2002).
Franklin, S.S. et al. Single versus combined blood pressure components and risk for cardiovascular disease: the Framingham Heart Study. Circulation 119, 243–250 (2009).
Lewington, S., Clarke, R., Qizilbash, N., Peto, R. & Collins, R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360, 1903–1913 (2002).
Devlin, B. & Roeder, K. Genomic control for association studies. Biometrics 55, 997–1004 (1999).
Kato, N. et al. Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure variation in east Asians. Nat. Genet. 43, 531–538 (2011).
Sesso, H.D. et al. Systolic and diastolic blood pressure, pulse pressure, and mean arterial pressure as predictors of cardiovascular disease risk in men. Hypertension 36, 801–807 (2000).
Darne, B., Girerd, X., Safar, M., Cambien, F. & Guize, L. Pulsatile versus steady component of blood pressure: a cross-sectional analysis and a prospective analysis on cardiovascular mortality. Hypertension 13, 392–400 (1989).
Blacher, J. & Safar, M.E. Large-artery stiffness, hypertension and cardiovascular risk in older patients. Nat. Clin. Pract. Cardiovasc. Med. 2, 450–455 (2005).
Dart, A.M. & Kingwell, B.A. Pulse pressure–a review of mechanisms and clinical relevance. J. Am. Coll. Cardiol. 37, 975–984 (2001).
Johnson, A.D. et al. Genome-wide meta-analyses identifies seven loci associated with platelet aggregation in response to agonists. Nat. Genet. 42, 608–613 (2010).
Soranzo, N. et al. A novel variant on chromosome 7q22.3 associated with mean platelet volume, counts, and function. Blood 113, 3831–3837 (2009).
Soranzo, N. et al. A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium. Nat. Genet. 41, 1182–1190 (2009).
Oudit, G.Y. et al. Phosphoinositide 3-kinase γ-deficient mice are protected from isoproterenol-induced heart failure. Circulation 108, 2147–2152 (2003).
Perrino, C. et al. Dynamic regulation of phosphoinositide 3-kinase-γ activity and β-adrenergic receptor trafficking in end-stage human heart failure. Circulation 116, 2571–2579 (2007).
Wågsäter, D. et al. ADAMTS-4 and -8 are inflammatory regulated enzymes expressed in macrophage-rich areas of human atherosclerotic plaques. Atherosclerosis 196, 514–522 (2008).
Ellis, P.D., Chen, Q., Barker, P.J., Metcalfe, J.C. & Kemp, P.R. Nov gene encodes adhesion factor for vascular smooth muscle cells and is dynamically regulated in response to vascular injury. Arterioscler. Thromb. Vasc. Biol. 20, 1912–1919 (2000).
Shimoyama, T. et al. CCN3 inhibits neointimal hyperplasia through modulation of smooth muscle cell growth and migration. Arterioscler. Thromb. Vasc. Biol. 30, 675–682 (2010).
Heath, E. et al. Abnormal skeletal and cardiac development, cardiomyopathy, muscle atrophy and cataracts in mice with a targeted disruption of the Nov (Ccn3) gene. BMC Dev. Biol. 8, 18 (2008).
Cools, J. et al. Fusion of a novel gene, BTL, to ETV6 in acute myeloid leukemias with a t(4;12)(q11-q12;p13). Blood 94, 1820–1824 (1999).
Kamatani, Y. et al. Genome-wide association study of hematological and biochemical traits in a Japanese population. Nat. Genet. 42, 210–215 (2010).
Dorn, G.W. II. Adrenergic signaling polymorphisms and their impact on cardiovascular disease. Physiol. Rev. 90, 1013–1062 (2010).
Kitsios, G.D. & Zintzaras, E. Synopsis and data synthesis of genetic association studies in hypertension for the adrenergic receptor family genes: the CUMAGAS-HYPERT database. Am. J. Hypertens. 23, 305–313 (2010).
Rohrer, D.K., Chruscinski, A., Schauble, E.H., Bernstein, D. & Kobilka, B.K. Cardiovascular and metabolic alterations in mice lacking both β1- and β2-adrenergic receptors. J. Biol. Chem. 274, 16701–16708 (1999).
Cheng, G., Qiao, F., Gallien, T.N., Kuppuswamy, D. & Cooper, G. IV. Inhibition of β-adrenergic receptor trafficking in adult cardiocytes by MAP4 decoration of microtubules. Am. J. Physiol. Heart Circ. Physiol. 288, H1193–H1202 (2005).
Li, Y. & Abecasis, G.R. Mach 1.0: Rapid haplotype reconstruction and missing genotype inference. Am. J. Hum. Genet. S79, 2290 (2006).
Marchini, J., Howie, B., Myers, S., McVean, G. & Donnelly, P. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat. Genet. 39, 906–913 (2007).
Servin, B. & Stephens, M. Imputation-based analysis of association studies: candidate regions and quantitative traits. PLoS Genet. 3, e114 (2007).